Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,818 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01603004 | Potential Molecular Predictors of Response to Novel Therapies in Metastatic Pancreatic Neuroendocrine Tumors | completed | — | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2019 | clinicaltrials |
| NCT03430908 | Blind Gastric Tube Placement: Incidence of Malposition Confirmed by Ultrasonography | completed | — | 166 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2019 |
| clinicaltrials |
| NCT01132755 | Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage | completed | Phase 2 | 112 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 14, 2019 | clinicaltrials |
| NCT03069950 | Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver | withdrawn | Phase 2 | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 21, 2019 | clinicaltrials |
| NCT03030885 | Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC) | completed | Phase 1 | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 5, 2019 | clinicaltrials |
| NCT00917462 | Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer | completed | Phase 2 | 35 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 27, 2019 | clinicaltrials |
| NCT02410577 | 89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme | completed | N/A | 2 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 19, 2019 | clinicaltrials |
| NCT00807599 | Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L | completed | Phase 2 | 67 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 15, 2019 | clinicaltrials |
| NCT02305498 | Yoga Practice for Breast or Ovarian Cancer Patients | completed | N/A | 39 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 14, 2019 | clinicaltrials |
| NCT00588679 | Magnetic Resonance Spectroscopic Imaging of the Prostate at 3 Tesla | completed | N/A | 265 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 8, 2019 | clinicaltrials |
| NCT03699384 | Safety and Clinical Activity Study of Combination Azacitidine and Avelumab in Patients With Acute Myeloid Leukemia (AML) and Minimal Residual Disease (MRD) | withdrawn | Phase 1 / Phase 2 | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 20, 2019 | clinicaltrials |
| NCT02320825 | Randomized Study Comparing Local Tumor Control After Post-Operative Single-Fraction or Hypofractionated Stereotactic Radiosurgery in the Treatment of Spinal Metastases | completed | Phase 3 | 16 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 19, 2019 | clinicaltrials |
| NCT02155465 | Trial of Ruxolitinib and Erlotinib in Patients With EGFR-mutant Lung Adenocarcinoma With Acquired Resistance to Erlotinib | completed | Phase 1 / Phase 2 | 22 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 16, 2019 | clinicaltrials |
| NCT01416974 | Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and Rituximab | completed | Phase 1 | 13 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 11, 2019 | clinicaltrials |
| NCT00877110 | Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma | completed | Phase 1 | 71 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 10, 2019 | clinicaltrials |
| NCT00295932 | Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma | completed | Phase 1 / Phase 2 | 79 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 20, 2018 | clinicaltrials |
| NCT00578630 | Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Bone Marrow Transplantation Patients | completed | — | 128 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 19, 2018 | clinicaltrials |
| NCT02833246 | Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications | completed | N/A | 28 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 19, 2018 | clinicaltrials |
| NCT01967095 | Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer | completed | Phase 1 | 53 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 13, 2018 | clinicaltrials |
| NCT02494206 | Immunotherapy for the Treatment of Breast Cancer Related Upper Extremity Lymphedema (BCRL) | completed | N/A | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 8, 2018 | clinicaltrials |
| NCT01262040 | Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive | completed | N/A | 154 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 7, 2018 | clinicaltrials |
| NCT00581958 | Radiation Biodosimetry in Patients Treated With Total Body Irradiation (TBI) | completed | — | 198 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 5, 2018 | clinicaltrials |
| NCT02023346 | Prognostic Awareness and Patient-Physician Communication in Malignant Glioma | completed | — | 95 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 1, 2018 | clinicaltrials |
| NCT01354951 | Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate Cancer | terminated | Phase 2 | 3 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 19, 2018 | clinicaltrials |
| NCT00870233 | Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life | completed | — | 120 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 15, 2018 | clinicaltrials |
| NCT01606787 | Mannitol Use During Partial Nephrectomy Prior to Renal Ischemia and Impact on Renal Function Outcomes | completed | Phase 3 | 210 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 15, 2018 | clinicaltrials |
| NCT00639106 | Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial | completed | Phase 3 | 70 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 3, 2018 | clinicaltrials |
| NCT00255801 | Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma | completed | Phase 2 | 37 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 16, 2018 | clinicaltrials |
| NCT01025453 | Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer | completed | Phase 2 | 37 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 15, 2018 | clinicaltrials |
| NCT02250911 | Care For The Cancer Caregiver: A Meaning-Based Workshop To Help Manage Caregiver Burden | completed | N/A | 88 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 10, 2018 | clinicaltrials |
| NCT01443078 | Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN) | completed | Phase 2 | 42 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 9, 2018 | clinicaltrials |
| NCT01598025 | Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor | terminated | N/A | 3 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 9, 2018 | clinicaltrials |
| NCT02297386 | [18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer | completed | Phase 1 | 3 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 6, 2018 | clinicaltrials |
| NCT01692223 | A Safety Study Assessing the Effects of Receiving Genome Sequencing Results | completed | — | 8 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 2, 2018 | clinicaltrials |
| NCT01262222 | Patients Undergoing Major Cancer Surgery: Incidence and Predictive Value for Postoperative Cardiac Events | completed | — | 67 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 13, 2018 | clinicaltrials |
| NCT00987480 | Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine | completed | Phase 2 | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 10, 2018 | clinicaltrials |
| NCT01181648 | Long-Term Impact of Human Papillomavirus (HPV) on Quality of Life | completed | — | 210 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 20, 2018 | clinicaltrials |
| NCT01716247 | Comparison of Contrast Enhanced Mammography to Breast MRI in Screening Patients at Increased Risk for Breast Cancer | completed | N/A | 1,000 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2018 | clinicaltrials |
| NCT02060253 | Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer | completed | Phase 1 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 14, 2018 | clinicaltrials |
| NCT01223235 | Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab | completed | N/A | 22 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 12, 2018 | clinicaltrials |
| NCT00504023 | Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva | completed | N/A | 8 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 6, 2018 | clinicaltrials |
| NCT02450591 | Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations | completed | N/A | 4 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 21, 2018 | clinicaltrials |
| NCT01323517 | Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Melanoma of The Extremity | completed | Phase 2 | 26 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 15, 2018 | clinicaltrials |
| NCT01200355 | Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome | completed | Phase 4 | 113 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 7, 2018 | clinicaltrials |
| NCT00706875 | A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors | completed | — | 59 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 30, 2018 | clinicaltrials |
| NCT00832598 | [18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors | completed | N/A | 13 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 27, 2018 | clinicaltrials |
| NCT00096629 | Vaccine Therapy in Treating Patients With Kidney Cancer | completed | Phase 1 | 15 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 25, 2018 | clinicaltrials |
| NCT03109977 | Imaging With a New Agent That Finds a Cancer Protein Called HER2 | completed | Phase 1 | 6 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 17, 2018 | clinicaltrials |
| NCT00746018 | Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy | completed | N/A | 39 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 11, 2018 | clinicaltrials |
| NCT01664936 | Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes | completed | — | 27 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 6, 2018 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials